Lb Pharmaceuticals
(NASDAQ) LBRX
Lb Pharmaceuticals Financials at a Glance
Market Cap
$806.39M
Revenue (TTM)
$0.00
Net Income (TTM)
$39.17M
EPS (TTM)
$-1.49
P/E Ratio
-18.93
Dividend
$0.00
Beta (Volatility)
1.07 (Average)
Dividend
$0.00
Beta (Volatility)
1.07 (Average)
Price
$28.18
Volume
145,378.26
Open
$28.50
Price
$28.18
Volume
145,378.26
Open
$28.50
Previous Close
$28.12
Daily Range
$27.93 - $29.71
52-Week Range
$13.36 - $33.47
Dividend
$0.00
Beta (Volatility)
1.07 (Average)
Price
$28.18
Volume
145,378.26
Open
$28.50
Previous Close
$28.12
Daily Range
$27.93 - $29.71
52-Week Range
$13.36 - $33.47
LBRX News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Lb Pharmaceuticals
Industry
Pharmaceuticals
Sector
Health CareEmployees
27
CEO
Heather D. Turner
Website
www.lbpharma.usHeadquarters
New York, NY 10119, US
LBRX Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-16%
Return on Capital
-12%
Return on Assets
-10%
Earnings Yield
-5.28%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$806.39M
Shares Outstanding
28.68M
Volume
145.38K
Avg. Volume
246.97K
Financials (TTM)
Gross Profit
$0.00
Operating Income
$30.40M
EBITDA
$30.08M
Operating Cash Flow
$35.21M
Capital Expenditure
$52.00K
Free Cash Flow
$35.26M
Cash & ST Invst.
$295.21M
Total Debt
$3.57M
Lb Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$82.00K
N/A
Gross Margin
0.00%
N/A
Market Cap
$806.39M
N/A
Market Cap/Employee
$50.40M
N/A
Employees
16
N/A
Net Income
$19.05M
-274.5%
EBITDA
$22.02M
-322.2%
Quarterly Fundamentals
Net Cash
$362.17M
+3361.1%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$2.74M
-9.6%
Short Term Debt
$730.00K
+0.0%
Return on Assets
-9.95%
N/A
Return on Invested Capital
-12.25%
N/A
Free Cash Flow
$23.32M
-186.2%
Operating Cash Flow
$23.29M
-186.5%